You are here

  • Home
  • Archive
  • Volume 9, Issue 8
  • Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma

 

Online download statistics by month:

Online download statistics by month: August 2021 to September 2025

AbstractFullPdf
Aug 202124424451
Sep 202131431750
Oct 202111611634
Nov 2021808129
Dec 2021798224
Jan 2022777831
Feb 2022495324
Mar 2022617232
Apr 2022808640
May 2022656525
Jun 2022486032
Jul 2022505120
Aug 2022636312
Sep 2022626217
Oct 2022656629
Nov 2022586028
Dec 2022313126
Jan 2023353716
Feb 2023555517
Mar 2023525426
Apr 2023212118
May 2023303019
Jun 2023313119
Jul 2023383818
Aug 2023333314
Sep 2023242410
Oct 2023323213
Nov 202336364
Dec 2023686826
Jan 2024687022
Feb 2024696920
Mar 2024575728
Apr 2024323214
May 2024505121
Jun 2024626322
Jul 2024565728
Aug 2024373817
Sep 2024292920
Oct 2024363726
Nov 2024414923
Dec 2024414420
Jan 2025434329
Feb 2025969722
Mar 2025505028
Apr 2025878735
May 2025616236
Jun 2025232320
Jul 2025110
Sep 2025110
Total293730061135